Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

Sometimes, the conversation doesn’t get past a handful of words, and just the attempt may threaten the patient-physician ...